Company Filing History:
Years Active: 1996-2012
Title: Marvin M Hansen: Innovator in Pharmaceutical Compounds
Introduction
Marvin M Hansen is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 12 patents. His work primarily focuses on developing innovative compounds that address various health conditions.
Latest Patents
One of Hansen's latest patents is titled "Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1." This invention discloses novel compounds of Formula I that exhibit 11-HSD type 1 antagonist activity. The patent also includes methods for preparing these compounds and pharmaceutical compositions that utilize them. These compositions are aimed at treating diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome, and other conditions associated with 11-HSD type 1 activity.
Another significant patent by Hansen is for "Indole derivatives for the treatment of depression and anxiety." This invention provides compounds of formula (I) that are useful for treating depression and anxiety, as well as alleviating symptoms caused by withdrawal from tobacco or nicotine.
Career Highlights
Marvin M Hansen is currently associated with Eli Lilly and Company, a leading pharmaceutical firm known for its innovative research and development. His work at Eli Lilly has allowed him to contribute to groundbreaking advancements in medicine.
Collaborations
Hansen has collaborated with notable coworkers, including Allen R Harkness and Benjamin Alan Anderson. These partnerships have further enhanced his research and development efforts in the pharmaceutical industry.
Conclusion
Marvin M Hansen is a distinguished inventor whose work has significantly impacted the pharmaceutical field. His innovative patents and collaborations continue to pave the way for advancements in treating various health conditions.